Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karl B. Thor is active.

Publication


Featured researches published by Karl B. Thor.


Advances in Experimental Medicine and Biology | 1995

Regenerative Bladder Augmentation: A Review of the Initial Preclinical Studies with Porcine Small Intestinal Submucosa

Bradley P. Kropp; Stephen F. Badylak; Karl B. Thor

The gastrointestinal tract has been the mainstay for bladder reconstruction in part due to the poor results with alloplastic materials.1 However, bowel is not the perfect substitute and is associated with infection, intestinal obstruction, mucus production, electrolyte abnormalities and carcinogenic conversion. Therefore, a substance that enlarges the bladder, does not violate the gastrointestinal tract, is non-immunogenic, and promotes bladder regeneration would be a useful alternative in genitourinary reconstruction.


Synapse | 1992

AUTORADIOGRAPHIC LOCALIZATION OF 5HT1 BINDING SITES IN AUTONOMIC AREAS OF THE RAT DORSOMEDIAL MEDULLA OBLONGATA

Karl B. Thor; Alisa Blitz-Siebert; Cinda J. Helke


Synapse | 1992

Autoradiographic localization of 5HT1 binding sites in the medulla oblongata of the rat.

Karl B. Thor; Alisa Blitz-Siebert; Cinda J. Helke


Archive | 1997

Methods of treating or preventing interstitial cystitis

Smriti Iyengar; Mark A. Muhlhauser; Karl B. Thor


Archive | 1992

Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence

Karl B. Thor


Archive | 1996

Method of treating urinary bladder dysfunctions

Mark A. Muhlhauser; Harlan E. Shannon; Karl B. Thor


Archive | 2001

1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatement of incontinence

John Mehnert Schaus; Dennis Charles Thompson; Karl B. Thor


Archive | 1994

Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives

Mark A. Muhlhauser; Harlan E. Shannon; Karl B. Thor


Archive | 2001

1-(2-m-methansulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine und ihre akzeptablen pharmazeutischen salze und solvate und ihre verwendung zur behandlung von inkontinenz

John Mehnert Schaus; Dennis Charles Thompson; Karl B. Thor


Archive | 2001

1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereof

John Mehnert Schaus; Dennis Charles Thompson; Karl B. Thor

Collaboration


Dive into the Karl B. Thor's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alisa Blitz-Siebert

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Cinda J. Helke

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Bradley P. Kropp

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge